Premium
DT‐02‐03: TARGET ENGAGEMENT IN AN AD TRIAL: CRENEZUMAB LOWERS Aβ OLIGOMER LEVELS IN CSF
Author(s) -
Yang Ting,
Dang Yifan,
Ostaszewski Beth,
Mengel David,
Steffen Verena,
Rabe Christina,
Bittner Tobias,
Walsh Dominic M.,
Selkoe Dennis J.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.012
Subject(s) - placebo , medicine , immunoassay , analysis of variance , clinical trial , gastroenterology , urology , antibody , immunology , pathology , alternative medicine